VDyne Transcatheter Tricuspid Valve Replacement System for tricuspid valve insufficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 4 Apr 2023: Trial registered, NCT05797519
  2. 8 May 2023: Trial registered, NCT05848284

The trials

NCT05797519: Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

State
Under way
Phase
No phase
People
120 planned
Started
1 Mar 2023
Primary completion
30 Dec 2026
Arms
VDyne System Treatment Arm
Results
None posted
  1. 1 Mar 2023: Trial started
  2. 4 Apr 2023: Trial registered

NCT05848284: Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

State
Under way
Phase
No phase
People
30 planned
Started
1 Apr 2024
Primary completion
30 Nov 2026
Arms
VDyne System Treatment Arm
Results
None posted
  1. 8 May 2023: Trial registered
  2. 1 Apr 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.